Modern Technology Corp. (MODC)
Oxford, AL, US
Modern Technology Corp. (MTC) offers a wide array of support and advisory services to both private and public sector enterprises. Its expertise covers crucial areas like fostering business growth, securing capital, product innovation, strategic corporate planning, brand management and public outreach, developing product distribution and marketing channels, and providing executive leadership consulting. Beyond its consultancy, MTC also leverages its portfolio investments to deliver advanced technological solutions. These include the GreenGen system, a complete package tailored for customers in the green fuels and sustainable power generation sectors, and the GenH System, a specialized hydrogen fuel injection technology engineered for the heavy-duty trucking industry. Founded in 1982, Modern Technology Corp. is headquartered in Oxford, Mississippi, and also maintains an office in Jackson, Mississippi.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | +0.00% | +150.00% | +150.00% | +150.00% | +150.00% | +100.00% | +9,900.00% | +0.00% | -100.00% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2024-06 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Biotechnology: +1.6%+272.7% ★
-
EPS growth Biotechnology: +29.7%-216.9%
-
FCF margin FCF growth · Biotechnology: +16.2%-61.0%
-
EBIT margin Biotechnology: +0.0%-63.9%
-
ROIC Biotechnology: -16.1%-282.1%
-
Share dilution Biotechnology: -3.4%+132.5%
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-0.82×
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Susan Cable | Vice President of Marketing | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for MODC
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
